Seegene, 288,454 Shares Net Sold by Individuals in Last 5 Days... Stock Price at 252,300 KRW (+2.44%)

As of 1:30 PM on the 31st, Seegene is trading at 252,300 KRW, up 2.44% from the previous day. The trading volume is 892,525 shares, which is about 81.22% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On August 27, Kim Chung-hyun, a researcher at Mirae Asset Daewoo, stated, "There is little cause for concern regarding the sharp slowdown in second-half performance. Sales from July to mid-August are similar to those in May and June. Q4 2020 is the flu season. Entering Phase 3 of COVID-19: the key is variant kits and All-in-One kits that combine flu virus detection. Compared to global companies, a significant dependence on COVID-19 diagnostic kit sales is a downside. If the global spread of COVID-19 enters a declining phase, stock price volatility is likely to increase." He set Seegene's target price at 268,800 KRW.

Over the past five days, individual investors have net sold 288,454 shares of Seegene, while foreigners and institutions have net bought 276,216 shares and 13,688 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.